Aqsens Health and Research Teams from Nanjing and Shanghai Replicate Large-Scale Prostate Cancer Cohort Measurements in China
Aqsens Health’s team traveled to Shanghai in early July to conduct prostate cancer analyses in collaboration with research teams from Nanjing and Shanghai. The goal of the trip was to analyze a large, well-designed urine sample cohort using the latest phage-biosensors and protocols, replicating insights gained in Finland. The Aqsens team also trained the Chinese research teams to continue the work independently after their return. This collaboration combines Finnish biotech innovation with China’s research talent, advanced capabilities, and strong interest in urine-based analysis.
Aqsens Health starting pre-clinical trials for urinary tract cancer detection in China
Aqsens Health and its Chinese partner OG Pharmaceuticals have received funding for a joint prostate and bladder cancer pre-clinical and clinical research project in Jiangsu Province in China.
Paving the way to the world’s largest single market – Interview with Aqsens Health’s Senior Project Manager Zhao Zhao
Zhao took the time to answer a few questions about her role at Aqsens, what she looks forward to when managing impactful projects in China , and what she thinks are the most important success factors when collaborating with Chinese partners.
BIOSALIVA – Aqsens Health and Shanghai Jiao Tong University begin research on early detection of lung cancer and tuberculosis
Aqsens Health and research teams from the Shanghai Jiao Tong University and Shanghai Public Health Clinical Center have received research funding from China’s Ministry of Science and Technology and Business Finland to start a research collaboration focusing on the detection of lung cancer and tuberculosis from saliva samples.
How AI is shaping the Medtech industry – Interview with Professor Wei Dongqing from Shanghai Jiao Tong University
We at Aqsens Health had the opportunity to interview Professor Wei Dongqing to discuss how AI is shaping the future of the healthcare industry ahead of Aqsens and Shanghai Jiao Tong University's upcoming research collaboration.
Time to put an end to TB – World Tuberculosis Day
Tuberculosis is a very complex health care problem that affects over 10 million people worldwide every year. It is treatable and curable, but still dangerous, especially to those with weakened immune systems…
Next practises and post-pandemic learnings for international research collaboration
Even a small company can greatly benefit from international collaborations, especially in the research and development phase. But why specifically should a health technology or biotechnology start-up look into the possibility of international collaboration?
Aqsens Health and OG Pharmaceuticals partner for an upcoming collaborative research project – Interview with OG Pharmaceuticals Founder & CEO Dr. Zhao Wanzhou
Dr. Zhao answered shared his views about the upcoming collaboration with Aqsens Health, the benefits of urine-based detection, and applying new cancer screening solutions in China.